Abstract
Much evidence has identified a direct anatomical and functional link between the brain and the immune system, with glucocorticoids (GCs), catecholamines (CAs), and neuropeptide Y (NPY) as its end-point mediators. This suggests the important role of these mediators in immune system homeostasis and the pathogenesis of inflammatory autoimmune diseases. However, although it is clear that these mediators can modulate lymphocyte maturation and the activity of distinct immune cell types, their putative role in the pathogenesis of autoimmune disease is not yet completely understood. We have contributed to this field by discovering the influence of CAs and GCs on fine-tuning thymocyte negative selection and, in particular, by pointing to the putative CA-mediated mechanisms underlying this influence. Furthermore, we have shown that CAs are implicated in the regulation of regulatory T-cell development in the thymus. Moreover, our investigations related to macrophage biology emphasize the complex interaction between GCs, CAs and NPY in the modulation of macrophage functions and their putative significance for the pathogenesis of autoimmune inflammatory diseases.
Similar content being viewed by others
References
Jankovic BD. Neuroimmune interactions: experimental and clinical strategies. Immunol Lett. 1987;16:341–53.
Besedovsky HO, Rey AD. Physiology of psychoneuroimmunology: a personal view. Brain Behav Immun. 2007;21:34–44.
Chrousos GP. Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J Allergy Clin Immunol. 2000;106:S275–91.
Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol. 1985;135:755s–65s.
Bedoui S, Lechner S, Gebhardt T, Nave H, Beck-Sickinger AG, Straub RH, Pabst R, von Horsten S. NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization. J Neuroimmunol. 2002;132:25–33.
Bedoui S, Kawamura N, Straub RH, Pabst R, Yamamura T, von Horsten S. Relevance of neuropeptide Y for the neuroimmune crosstalk. J Neuroimmunol. 2003;134:1–11.
Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve–an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000;52:595–638.
Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol. 2002;20:125–63.
Wilckens T, De Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today. 1997;18:418–24.
Dimitrijevic M, Stanojevic S, Micic S, Vujic V, Kovacevic-Jovanovic V, Mitic K, von Horsten S, Kosec D. Neuropeptide Y (NPY) modulates oxidative burst and nitric oxide production in carrageenan-elicited granulocytes from rat air pouch. Peptides. 2006;27:3208–15.
Dimitrijevic M, Stanojevic S, Mitic K, Kustrimovic N, Vujic V, Miletic T, Kovacevic-Jovanovic V. The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age. Peptides. 2008;29:2179–87.
Dimitrijevic M, Stanojevic S, Mitic K, Kustrimovic N, Vujic V, Miletic T, Kovacevic-Jovanovic V. Modulation of granulocyte functions by peptide YY in the rat: age-related differences in Y receptors expression and plasma dipeptidyl peptidase 4 activity. Regul Pept. 2010;159:100–9.
Dimitrijevic M, Stanojevic S, Vujic V, Beck-Sickinger A, von Horsten S. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors. Regul Pept. 2005;124:163–72.
Dimitrijevic M, Stanojevic S, Vujic V, Kovacevic-Jovanovic V, Beck-Sickinger A, Demuth H, von Horsten S. Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26). J Neuroimmunol. 2002;129:35–42.
Mitic K, Stanojevic S, Kustrimovic N, Vujic V, Dimitrijevic M. Neuropeptide Y modulates functions of inflammatory cells in the rat: distinct role for Y1, Y2 and Y5 receptors. Peptides. 2011;32:1626–33.
Stanojevic S, Mitic K, Vujic V, Kovacevic-Jovanovic V, Dimitrijevic M. Exposure to acute physical and psychological stress alters the response of rat macrophages to corticosterone, neuropeptide Y and beta-endorphin. Stress. 2007;10:65–73.
Stanojevic S, Vujic V, Kovacevic-Jovanovic V, Mitic K, Kosec D, Horsten S, Dimitrijevic M. Age-related effect of peptide YY (PYY) on paw edema in the rat: the function of Y1 receptors on inflammatory cells. Exp Gerontol. 2006;41:793–9.
Rogers MP, Fozdar M. Psychoneuroimmunology of autoimmune disorders. Adv Neuroimmunol. 1996;6:169–77.
Elenkov IJ, Chrousos GP. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab. 1999;10:359–68.
Sternberg EM. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol. 2001;169:429–35.
Tonelli L, Webster JI, Rapp KL, Sternberg E. Neuroendocrine responses regulating susceptibility and resistance to autoimmune/inflammatory disease in inbred rat strains. Immunol Rev. 2001;184:203–11.
Heesen C, Mohr DC, Huitinga I, Bergh FT, Gaab J, Otte C, Gold SM. Stress regulation in multiple sclerosis: current issues and concepts. Mult Scler. 2007;13:143–8.
Hemmer B, Archelos JJ, Hartung HP. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci. 2002;3:291–301.
Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005;23:683–747.
Ackerman KD, Stover A, Heyman R, Anderson BP, Houck PR, Frank E, Rabin BS, Baum A. Robert Ader New Investigator award. Relationship of cardiovascular reactivity, stressful life events, and multiple sclerosis disease activity. Brain Behav Immun. 2003;17:141–51.
Franklin GM, Heaton RK, Nelson LM, Filley CM, Seibert C. Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. Neurology. 1988;38:1826–9.
Goodin DS, Ebers GC, Johnson KP, Rodriguez M, Sibley WA, Wolinsky JS. The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1999;52:1737–45.
Grant I, Brown GW, Harris T, McDonald WI, Patterson T, Trimble MR. Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1989;52:8–13.
Mohr DC, Goodkin DE, Bacchetti P, Boudewyn AC, Huang L, Marrietta P, Cheuk W, Dee B. Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology. 2000;55:55–61.
Nisipeanu P, Korczyn AD. Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology. 1993;43:1311–2.
Sibley WA, Bamford CR, Clark K, Smith MS, Laguna JF. A prospective study of physical trauma and multiple sclerosis. J Neurol Neurosurg Psychiatry. 1991;54:584–9.
Schreiner B, Heppner FL, Becher B. Modeling multiple sclerosis in laboratory animals. Semin Immunopathol. 2009;31:479–95.
Sriram S, Steinman L. Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes. J Exp Med. 1983;158:1362–7.
Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 1988;239:290–2.
Becher B, Prat A, Antel JP. Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia. 2000;29:293–304.
Bukilica M, Djordjevic S, Maric I, Dimitrijevic M, Markovic BM, Jankovic BD. Stress-induced suppression of experimental allergic encephalomyelitis in the rat. Int J Neurosci. 1991;59:167–75.
Chandler N, Jacobson S, Esposito P, Connolly R, Theoharides TC. Acute stress shortens the time to onset of experimental allergic encephalomyelitis in SJL/J mice. Brain Behav Immun. 2002;16:757–63.
Correa SG, Rodriguez-Galan MC, Rivero VE, Riera CM. Chronic varied stress modulates experimental autoimmune encephalomyelitis in Wistar rats. Brain Behav Immun. 1998;12:134–48.
Dimitrijevic M, Laban O, von Hoersten S, Markovic BM, Jankovic BD. Neonatal sound stress and development of experimental allergic encephalomyelitis in Lewis and DA rats. Int J Neurosci. 1994;78:135–43.
Kuroda Y, McEwen BS. Effect of chronic restraint stress and tianeptine on growth factors, growth-associated protein-43 and microtubule-associated protein 2 mRNA expression in the rat hippocampus. Brain Res Mol Brain Res. 1998;59:35–9.
Laban O, Dimitrijevic M, von Hoersten S, Markovic BM, Jankovic BD. Experimental allergic encephalomyelitis in adult DA rats subjected to neonatal handling or gentling. Brain Res. 1995;676:133–40.
Laban O, Markovic BM, Dimitrijevic M, Jankovic BD. Maternal deprivation and early weaning modulate experimental allergic encephalomyelitis in the rat. Brain Behav Immun. 1995;9:9–19.
Perez-Nievas BG, Garcia-Bueno B, Madrigal JL, Leza JC. Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated. J Neuroinflammation. 2010;7:60.
Teunis MA, Heijnen CJ, Sluyter F, Bakker JM, Van Dam AM, Hof M, Cools AR, Kavelaars A. Maternal deprivation of rat pups increases clinical symptoms of experimental autoimmune encephalomyelitis at adult age. J Neuroimmunol. 2002;133:30–8.
Columba-Cabezas S, Iaffaldano G, Chiarotti F, Alleva E, Cirulli F. Early handling increases susceptibility to experimental autoimmune encephalomyelitis (EAE) in C57BL/6 male mice. J Neuroimmunol. 2009;212:10–6.
Stephan M, Straub RH, Breivik T, Pabst R, von Horsten S. Postnatal maternal deprivation aggravates experimental autoimmune encephalomyelitis in adult Lewis rats: reversal by chronic imipramine treatment. Int J Dev Neurosci. 2002;20:125–32.
Meaney MJ, Diorio J, Francis D, Widdowson J, LaPlante P, Caldji C, Sharma S, Seckl JR, Plotsky PM. Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress. Dev Neurosci. 1996;18:49–72.
van Oers HJ, de Kloet ER, Levine S. Early vs. late maternal deprivation differentially alters the endocrine and hypothalamic responses to stress. Brain Res Dev Brain Res. 1998;111:245–52.
Stahn C, Lowenberg M, Hommes DW, Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol. 2007;275:71–8.
Mason D, MacPhee I, Antoni F. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology. 1990;70:1–5.
Stefferl A, Linington C, Holsboer F, Reul JM. Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat. Endocrinology. 1999;140:4932–8.
Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, Wilder RL. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA. 1989;86:2374–8.
Harbuz MS, Leonard JP, Lightman SL, Cuzner ML. Changes in hypothalamic corticotrophin-releasing factor and anterior pituitary pro-opiomelanocortin mRNA during the course of experimental allergic encephalomyelitis. J Neuroimmunol. 1993;45:127–32.
MacPhee IA, Antoni FA, Mason DW. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med. 1989;169:431–45.
Stefferl A, Storch MK, Linington C, Stadelmann C, Lassmann H, Pohl T, Holsboer F, Tilders FJ, Reul JM. Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone. Endocrinology. 2001;142:3616–24.
Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, Gold PW. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab. 1994;79:848–53.
Karaszewski JW, Reder AT, Maselli R, Brown M, Arnason BG. Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis. Ann Neurol. 1990;27:366–72.
Zoukos Y, Leonard JP, Thomaides T, Thompson AJ, Cuzner ML. beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1. Ann Neurol. 1992;31:657–62.
Giorelli M, Livrea P, Trojano M. Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients. J Neuroimmunol. 2004;155:143–9.
Muthyala S, Wiegmann K, Kim DH, Arnason BG, Chelmicka-Schorr E. Experimental allergic encephalomyelitis, beta-adrenergic receptors and interferon gamma-secreting cells in beta-adrenergic agonist-treated rats. Int J Immunopharmacol. 1995;17:895–901.
Vroon A, Kavelaars A, Limmroth V, Lombardi MS, Goebel MU, Van Dam AM, Caron MG, Schedlowski M, Heijnen CJ. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Immunol. 2005;174:4400–6.
Cosentino M, Bombelli R, Ferrari M, Marino F, Rasini E, Maestroni GJ, Conti A, Boveri M, Lecchini S, Frigo G. HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines. Life Sci. 2000;68:283–95.
Cosentino M, Zaffaroni M, Ferrari M, Marino F, Bombelli R, Rasini E, Frigo G, Ghezzi A, Comi G, Lecchini S. Interferon-gamma and interferon-beta affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis. J Neuroimmunol. 2005;162:112–21.
Rajda C, Bencsik K, Vecsei LL, Bergquist J. Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients. J Neuroimmunol. 2002;124:93–100.
Bohn MC, McEwen B, Luine VN, Black IB. Development and characterization of glucocorticoid receptors in rat superior cervical ganglion. Brain Res. 1984;316:211–8.
Cotecchia S, De Blasi A. Glucocorticoids increase beta-adrenoceptors on human intact lymphocytes in vitro. Life Sci. 1984;35:2359–64.
Levine S, Sowinski R, Steinetz B. Effects of experimental allergic encephalomyelitis on thymus and adrenal: relation to remission and relapse. Proc Soc Exp Biol Med. 1980;165:218–24.
Pekarski O, Bjork J, Hedlund G, Andersson G. The inhibitory effect in experimental autoimmune encephalomyelitis by the immunomodulatory drug Linomide (PNU-212616) is not mediated via release of endogenous glucocorticoids. Autoimmunity. 1998;28:235–41.
Dimitrijevic M, Rauski A, Radojevic K, Kosec D, Stanojevic S, Pilipovic I, Leposavic G. Beta-adrenoceptor blockade ameliorates the clinical course of experimental allergic encephalomyelitis and diminishes its aggravation in adrenalectomized rats. Eur J Pharmacol. 2007;577:170–82.
Chelmicka-Schorr E, Checinski M, Arnason BG. Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J Neuroimmunol. 1988;17:347–50.
Pal E, Yamamura T, Tabira T. Autonomic regulation of experimental autoimmune encephalomyelitis in IL-4 knockout mice. J Neuroimmunol. 1999;100:149–55.
Bedoui S, Miyake S, Lin Y, Miyamoto K, Oki S, Kawamura N, Beck-Sickinger A, von Horsten S, Yamamura T. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J Immunol. 2003;171:3451–8.
Maeda K, Yasuda M, Kaneda H, Maeda S, Yamadori A. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man. Neuropeptides. 1994;27:323–32.
Haerter K, Vroon A, Kavelaars A, Heijnen CJ, Limmroth V, Espinosa E, Schedlowski M, Elsenbruch S. In vitro adrenergic modulation of cellular immune functions in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2004;146:126–32.
Heijnen CJ, Rouppe van der Voort C, Wulffraat N, van der Net J, Kuis W, Kavelaars A. Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J Neuroimmunol. 1996;71:223–6.
Kohm AP, Tang Y, Sanders VM, Jones SB. Activation of antigen-specific CD4 + Th2 cells and B cells in vivo increases norepinephrine release in the spleen and bone marrow. J Immunol. 2000;165:725–33.
Gruber-Olipitz M, Stevenson R, Olipitz W, Wagner E, Gesslbauer B, Kungl A, Schauenstein K. Transcriptional pattern analysis of adrenergic immunoregulation in mice. Twelve hours norepinephrine treatment alters the expression of a set of genes involved in monocyte activation and leukocyte trafficking. J Neuroimmunol. 2004;155:136–42.
Rogausch H, del Rey A, Oertel J, Besedovsky HO. Norepinephrine stimulates lymphoid cell mobilization from the perfused rat spleen via beta-adrenergic receptors. Am J Physiol. 1999;276:R724–30.
van der Veen RC, Dietlin TA, Dixon Gray J, Gilmore W. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells. Cell Immunol. 2000;199:43–9.
Dimitrijevic M, Pilipovic I, Stanojevic S, Mitic K, Radojevic K, Pesic V, Leposavic G. Chronic propranolol treatment affects expression of adrenoceptors on peritoneal macrophages and their ability to produce hydrogen peroxide and nitric oxide. J Neuroimmunol. 2009;211:56–65.
Bhowmick S, Singh A, Flavell RA, Clark RB, O’Rourke J, Cone RE. The sympathetic nervous system modulates CD4(+)FoxP3(+) regulatory T cells via a TGF-beta-dependent mechanism. J Leukoc Biol. 2009;86:1275–83.
Palmer E. Negative selection–clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol. 2003;3:383–91.
Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol. 2005;5:772–82.
Nomura T, Sakaguchi S. Foxp3 and Aire in thymus-generated Treg cells: a link in self-tolerance. Nat Immunol. 2007;8:333–4.
Benlagha K, Wei DG, Veiga J, Teyton L, Bendelac A. Characterization of the early stages of thymic NKT cell development. J Exp Med. 2005;202:485–92.
Konkel JE, Maruyama T, Carpenter AC, Xiong Y, Zamarron BF, Hall BE, Kulkarni AB, Zhang P, Bosselut R, Chen W. Control of the development of CD8alphaalpha + intestinal intraepithelial lymphocytes by TGF-beta. Nat Immunol. 2011;12:312–9.
Gerli R, Paganelli R, Cossarizza A, Muscat C, Piccolo G, Barbieri D, Mariotti S, Monti D, Bistoni O, Raiola E, Venanzi FM, Bertotto A, Franceschi C. Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol. 1999;103:865–72.
Suri-Payer E, Wei K, Tung K. The day-3 thymectomy model for induction of multiple organ-specific autoimmune diseases. Curr Protoc Immunol 2001;Chapter 15:Unit 15, 16.
Haas J, Fritzsching B, Trubswetter P, Korporal M, Milkova L, Fritz B, Vobis D, Krammer PH, Suri-Payer E, Wildemann B. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol. 2007;179:1322–30.
Chen X, Fang L, Song S, Guo TB, Liu A, Zhang JZ. Thymic regulation of autoimmune disease by accelerated differentiation of Foxp3 + regulatory T cells through IL-7 signaling pathway. J Immunol. 2009;183:6135–44.
Ben-Nun A, Ron Y, Cohen IR. Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing. Nature. 1980;288:389–90.
Dominguez-Gerpe L, Rey-Mendez M. Role of pre-T cells and chemoattractants on stress-associated thymus involution. Scand J Immunol. 2000;52:470–6.
Pearse G. Histopathology of the thymus. Toxicol Pathol. 2006;34:515–47.
Schuurman HJ, Van Loveren H, Rozing J, Vos JG. Chemicals trophic for the thymus: risk for immunodeficiency and autoimmunity. Int J Immunopharmacol. 1992;14:369–75.
Prelog M. Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev. 2006;5:136–9.
Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000;21:55–89.
Dardenne M, Itoh T, Homo-Delarche F. Presence of glucocorticoid receptors in cultured thymic epithelial cells. Cell Immunol. 1986;100:112–8.
Talaber G, Kvell K, Varecza Z, Boldizsar F, Parnell SM, Jenkinson EJ, Anderson G, Berki T, Pongracz JE. Wnt-4 protects thymic epithelial cells against dexamethasone-induced senescence. Rejuvenation Res. 2011;14:241–8.
Berki T, Palinkas L, Boldizsar F, Nemeth P. Glucocorticoid (GC) sensitivity and GC receptor expression differ in thymocyte subpopulations. Int Immunol. 2002;14:463–9.
Boldizsar F, Palinkas L, Czompoly T, Bartis D, Nemeth P, Berki T. Low glucocorticoid receptor (GR), high Dig2 and low Bcl-2 expression in double positive thymocytes of BALB/c mice indicates their endogenous glucocorticoid hormone exposure. Immunobiology. 2006;211:785–96.
Butts CL, Shukair SA, Duncan KM, Harris CW, Belyavskaya E, Sternberg EM. Evaluation of steroid hormone receptor protein expression in intact cells using flow cytometry. Nucl Recept Signal. 2007;5:e007.
Boldizsar F, Talaber G, Szabo M, Bartis D, Palinkas L, Nemeth P, Berki T. Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells. Immunobiology. 2010;215:521–6.
Pesic V, Kosec D, Radojevic K, Pilipovic I, Perisic M, Vidic-Dankovic B, Leposavic G. Expression of alpha1-adrenoceptors on thymic cells and their role in fine tuning of thymopoiesis. J Neuroimmunol. 2009;214:55–66.
Leposavic G, Pilipovic I, Perisic M. Age-associated remodeling of neural and nonneural thymic catecholaminergic network affects thymopoietic productivity. NeuroImmunoModulation. 2011;18:290–308.
Leposavic G, Pilipovic I, Perisic M. Cellular and nerve fibre catecholaminergic thymic network: steroid hormone dependent activity. Physiol Res. 2011;60(Suppl 1):S71–82.
Leposavic G, Pilipovic I, Radojevic K, Pesic V, Perisic M, Kosec D. Catecholamines as immunomodulators: a role for adrenoceptor-mediated mechanisms in fine tuning of T-cell development. Auton Neurosci. 2008;144:1–12.
Boinet E. Recherches experimetales sur les fonctions des capsules surrenales. CRSeances Soc Biol Fil. 1899;51:671–4.
Jaffe HL. The influence of the supradrenal gland on the thymus. I. Regeneration of the thymus following double supradrenalectomy in the rat. J Exp Med. 1924;40:325–41.
Jaffe HL. The influence of the suprarenal gland on the thymus. III. Stimulatin of the growth of the thymus gland following double supradrenalectomy in young rats. J Exp Med. 1924;40:753–9.
Selye H. Thymus and adrenals in the response of the organism to injuries and intoxication. Br J Exp Pathol. 1936;17:234–48.
Star P. An unusual case of Addison’s disease; sudden death; remarks. Lancet. 1895;1:284.
Stojic-Vukanic Z, Rauski A, Kosec D, Radojevic K, Pilipovic I, Leposavic G. Dysregulation of T-cell development in adrenal glucocorticoid-deprived rats. Exp Biol Med (Maywood). 2009;234:1067–74.
Dougherty TF, White A. Effect of pituitary adrenotropic hormone on lymphoid tissue. Proc Soc Exp Biol Med. 1943;53:132–3.
Ashwell JD, Lu FW, Vacchio MS. Glucocorticoids in T cell development and function*. Annu Rev Immunol. 2000;18:309–45.
Jondal M, Pazirandeh A, Okret S. Different roles for glucocorticoids in thymocyte homeostasis? Trends Immunol. 2004;25:595–600.
Wiegers GJ, Kaufmann M, Tischner D, Villunger A. Shaping the T-cell repertoire: a matter of life and death. Immunol Cell Biol. 2011;89:33–9.
Durant S. In vivo effects of catecholamines and glucocorticoids on mouse thymic cAMP content and thymolysis. Cell Immunol. 1986;102:136–43.
Singh U. Effect of catecholamines on lymphopoiesis in fetal mouse thymic explants. J Anat. 1979;129:279–92.
Singh U, Owen JJ. Studies on the maturation of thymus stem cells. The effects of catecholamines, histamine and peptide hormones on the expression of T cell alloantigens. Eur J Immunol. 1976;6:59–62.
Leposavic G, Arsenovic-Ranin N, Radojevic K, Kosec D, Pesic V, Vidic-Dankovic B, Plecas-Solarovic B, Pilipovic I. Characterization of thymocyte phenotypic alterations induced by long-lasting beta-adrenoceptor blockade in vivo and its effects on thymocyte proliferation and apoptosis. Mol Cell Biochem. 2006;285:87–99.
Madden KS, Felten DL. Beta-adrenoceptor blockade alters thymocyte differentiation in aged mice. Cell Mol Biol (Noisy-le-grand) 2001;47:189–96.
Leposavic G, Pesic V, Stojic-Vukanic Z, Radojevic K, Arsenovic-Ranin N, Kosec D, Perisic M, Pilipovic I. Age-associated plasticity of alpha1-adrenoceptor-mediated tuning of T-cell development. Exp Gerontol. 2010;45:918–35.
Pesic V, Plecas-Solarovic B, Radojevic K, Kosec D, Pilipovic I, Perisic M, Leposavic G. Long-term beta-adrenergic receptor blockade increases levels of the most mature thymocyte subsets in aged rats. Int Immunopharmacol. 2007;7:674–86.
Pilipovic I, Kosec D, Radojevic K, Perisic M, Pesic V, Stojic-Vukanic Z, Leposavi G. Glucocorticoids, master modulators of the thymic catecholaminergic system? Braz J Med Biol Res. 2010;43:279–84.
Iwata M, Hanaoka S, Sato K. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire. Eur J Immunol. 1991;21:643–8.
Zacharchuk CM, Mercep M, Chakraborti PK, Simons SS Jr, Ashwell JD. Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. J Immunol. 1990;145:4037–45.
Zilberman Y, Yefenof E, Oron E, Dorogin A, Guy R. T cell receptor-independent apoptosis of thymocyte clones induced by a thymic epithelial cell line is mediated by steroids. Cell Immunol. 1996;170:78–84.
Zilberman Y, Zafrir E, Ovadia H, Yefenof E, Guy R, Sionov RV. The glucocorticoid receptor mediates the thymic epithelial cell-induced apoptosis of CD4 + 8 + thymic lymphoma cells. Cell Immunol. 2004;227:12–23.
Perez AR, Roggero E, Nicora A, Palazzi J, Besedovsky HO, Del Rey A, Bottasso OA. Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behav Immun. 2007;21:890–900.
Pruett SB, Padgett EL. Thymus-derived glucocorticoids are insufficient for normal thymus homeostasis in the adult mouse. BMC Immunol. 2004;5:24.
Buttgereit F, Brand MD, Burmester GR. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol. 1999;58:363–8.
Gametchu B, Watson CS, Wu S. Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leukemic patients. FASEB J. 1993;7:1283–92.
Orchinik M, Murray TF, Moore FL. A corticosteroid receptor in neuronal membranes. Science. 1991;252:1848–51.
Iglesias-Serret D, de Frias M, Santidrian AF, Coll-Mulet L, Cosialls AM, Barragan M, Domingo A, Gil J, Pons G. Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cells. Leukemia. 2007;21:281–7.
Ley R, Balmanno K, Hadfield K, Weston C, Cook SJ. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein. Bim. J Biol Chem. 2003;278:18811–6.
Tsitoura DC, Rothman PB. Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4 + T cells. J Clin Invest. 2004;113:619–27.
Lowenberg M, Verhaar AP, Bilderbeek J, Marle J, Buttgereit F, Peppelenbosch MP, van Deventer SJ, Hommes DW. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep. 2006;7:1023–9.
Lechner O, Wiegers GJ, Oliveira-Dos-Santos AJ, Dietrich H, Recheis H, Waterman M, Boyd R, Wick G. Glucocorticoid production in the murine thymus. Eur J Immunol. 2000;30:337–46.
Pazirandeh A, Xue Y, Rafter I, Sjovall J, Jondal M, Okret S. Paracrine glucocorticoid activity produced by mouse thymic epithelial cells. FASEB J. 1999;13:893–901.
Vacchio MS, Papadopoulos V, Ashwell JD. Steroid production in the thymus: implications for thymocyte selection. J Exp Med. 1994;179:1835–46.
Qiao S, Chen L, Okret S, Jondal M. Age-related synthesis of glucocorticoids in thymocytes. Exp Cell Res. 2008;314:3027–35.
Qiao S, Okret S, Jondal M. Thymocyte-synthesized glucocorticoids play a role in thymocyte homeostasis and are down-regulated by adrenocorticotropic hormone. Endocrinology. 2009;150:4163–9.
Taves MD, Gomez-Sanchez CE, Soma KK. Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function. Am J Physiol Endocrinol Metab. 2011;301:E11–24.
Pilipovic I, Radojevic K, Perisic M, Nacka-Aleksic M, Djikic J, Leposavic G. Circulating and thymic-derived glucocorticoids influence expression of key enzymes controlling the metabolism of catecholamines and adrenoceptors in thymocytes. NeuroImmunoModulation. 2011;18:398.
Shimizu T, Kawamura T, Miyaji C, Oya H, Bannai M, Yamamoto S, Weerasinghe A, Halder RC, Watanabe H, Hatakeyama K, Abo T. Resistance of extrathymic T cells to stress and the role of endogenous glucocorticoids in stress associated immunosuppression. Scand J Immunol. 2000;51:285–92.
Leposavic G, Radojevic K, Vidic-Dankovic B, Kosec D, Pilipovic I, Perisic M. Early postnatal castration affects thymic and thymocyte noradrenaline levels and beta-adrenoceptor-mediated influence on the thymopoiesis in adult rats. J Neuroimmunol. 2007;182:100–15.
Rauski A, Kosec D, Vidic-Dankovic B, Radojevic K, Plecas-Solarovic B, Leposavic G. Thymopoiesis following chronic blockade of beta-adrenoceptors. Immunopharmacol Immunotoxicol. 2003;25:513–28.
Williams AF, Gagnon J. Neuronal cell Thy-1 glycoprotein: homology with immunoglobulin. Science. 1982;216:696–703.
Killeen N. T-cell regulation: Thy-1—hiding in full view. Curr Biol. 1997;7:R774–7.
Morris R. Thy-1, the enigmatic extrovert on the neuronal surface. BioEssays. 1992;14:715–22.
Hueber AO, Bernard AM, Battari CL, Marguet D, Massol P, Foa C, Brun N, Garcia S, Stewart C, Pierres M, He HT. Thymocytes in Thy-1-/- mice show augmented TCR signaling and impaired differentiation. Curr Biol. 1997;7:705–8.
Wajeman-Chao SA, Lancaster SA, Graf H Jr, Chamber DA. Mechanism of catecholamine-mediated destabilization of messenger RNA encoding Thy-1 protein in T-Lineage Cells. J Immunol. 1998;161:4825–33.
LaJevic MD, Koduvayur SP, Caffrey V, Cohen RL, Chambers DA. Thy-1 mRNA destabilization by norepinephrine a 3’ UTR cAMP responsive decay element and involves RNA binding proteins. Brain Behav Immun. 2010;24:1078–88.
Wang L, Pino-Lagos K, de Vries VC, Guleria I, Sayegh MH, Noelle RJ. Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3 + CD4 + regulatory T cells. Proc Natl Acad Sci USA. 2008;105:9331–6.
Cosentino M, Fietta AM, Ferrari M, Rasini E, Bombelli R, Carcano E, Saporiti F, Meloni F, Marino F, Lecchini S. Human CD4 + CD25 + regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood. 2007;109:632–42.
Pilipovic I, Vidic-Dankovic B, Perisic M, Radojevic K, Colic M, Todorovic V, Leposavic G. Sexual dimorphism in the catecholamine-containing thymus microenvironment: a role for gonadal hormones. J Neuroimmunol. 2008;195:7–20.
Josefsson E, Bergquist J, Ekman R, Tarkowski A. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology. 1996;88:140–6.
Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol. 1998;161:3767–75.
Forde EA, Dogan RN, Karpus WJ. CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function. J Neuroimmunol. 2011;236:17–26.
Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD. Macrophages and neurodegeneration. Brain Res Brain Res Rev. 2005;48:185–95.
Bogie JF, Stinissen P, Hellings N, Hendriks JJ. Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation. J Neuroinflammation. 2011;8:85.
Pozzi LA, Maciaszek JW, Rock KL. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J Immunol. 2005;175:2071–81.
Almolda B, Gonzalez B, Castellano B. Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. Front Biosci. 2011;16:1157–71.
Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol. 2004;251:261–8.
Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA. 2004;101:12646–51.
Miletic T, Kovacevic-Jovanovic V, Vujic V, Stanojevic S, Mitic K, Lazarevic-Macanovic M, Dimitrijevic M. Reactive oxygen species (ROS), but not nitric oxide (NO), contribute to strain differences in the susceptibility to experimental arthritis in rats. Immunobiology. 2007;212:95–105.
Mitic K, Stanojevic S, Kustrimovic N, Dimitrijevic M. Strain differences in peritoneal macrophage activity and susceptibility to experimental allergic encephalomyelitis induction in rats. Inflamm Res. 2007;56(suppl 3):S495–8.
Ruuls SR, Bauer J, Sontrop K, Huitinga I, t Hart BA, Dijkstra CD. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol. 1995;56:207–17.
Lopes F, Coelho FM, Costa VV, Vieira EL, Sousa LP, Silva TA, Vieira LQ, Teixeira MM, Pinho V. Resolution of neutrophilic inflammation by H2O2 in antigen-induced arthritis. Arthritis Rheum. 2011;63:2651–60.
Lukic ML, Mensah-Brown E, Galadari S, Shahin A. Lack of apoptosis of infiltrating cells as the mechanism of high susceptibility to EAE in DA rats. Dev Immunol. 2001;8:193–200.
Sheng KC, Pietersz GA, Tang CK, Ramsland PA, Apostolopoulos V. Reactive oxygen species level defines two functionally distinctive stages of inflammatory dendritic cell development from mouse bone marrow. J Immunol. 2010;184:2863–72.
Barbouti A, Doulias PT, Nousis L, Tenopoulou M, Galaris D. DNA damage and apoptosis in hydrogen peroxide-exposed Jurkat cells: bolus addition versus continuous generation of H2O2. Free Radic Biol Med. 2002;33:691–702.
Holler J, Zakrzewicz A, Kaufmann A, Wilhelm J, Fuchs-Moll G, Dietrich H, Padberg W, Kuncova J, Kummer W, Grau V. Neuropeptide Y is expressed by rat mononuclear blood leukocytes and strongly down-regulated during inflammation. J Immunol. 2008;181:6906–12.
Rosmaninho-Salgado J, Araujo IM, Alvaro AR, Mendes AF, Ferreira L, Grouzmann E, Mota A, Duarte EP, Cavadas C. Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1beta: role of neuropeptide Y and nitric oxide. J Neurochem. 2009;109:911–22.
O’Connor KA, Johnson JD, Hammack SE, Brooks LM, Spencer RL, Watkins LR, Maier SF. Inescapable shock induces resistance to the effects of dexamethasone. Psychoneuroendocrinology. 2003;28:481–500.
Tsukada F, Sugawara M, Kohno H, Ohkubo Y. Evaluation of the effects of restraint and footshock stress on small intestinal motility by an improved method using a radionuclide, 51Cr, in the rat. Biol Pharm Bull. 2001;24:488–90.
Zhou JY, Zhong HJ, Yang C, Yan J, Wang HY, Jiang JX. Corticosterone exerts immunostimulatory effects on macrophages via endoplasmic reticulum stress. Br J Surg. 2010;97:281–93.
Quan N, Avitsur R, Stark JL, He L, Lai W, Dhabhar F, Sheridan JF. Molecular mechanisms of glucocorticoid resistance in splenocytes of socially stressed male mice. J Neuroimmunol. 2003;137:51–8.
Fleshner M, Deak T, Spencer RL, Laudenslager ML, Watkins LR, Maier SF. A long-term increase in basal levels of corticosterone and a decrease in corticosteroid-binding globulin after acute stressor exposure. Endocrinology. 1995;136:5336–42.
van der Veen RC, Hinton DR, Incardonna F, Hofman FM. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J Neuroimmunol. 1997;77:1–7.
Cowden WB, Cullen FA, Staykova MA, Willenborg DO. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J Neuroimmunol. 1998;88:1–8.
Gold DP, Schroder K, Powell HC, Kelly CJ. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur J Immunol. 1997;27:2863–9.
Staykova MA, Paridaen JT, Cowden WB, Willenborg DO. Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis. Am J Pathol. 2005;166:147–57.
Mitic K, Miletic T, Kovacevic-Jovanovic V, Kustrimovic N, Kosec D, Dimitrijevic M, Stanojevic S. Phenotype changes induced by immunization with encephalitogen affected the functions of peritoneal macrophages in two rat strains with different sensitivity to experimental autoimmune encephalomyelitis (EAE) induction. Acta Veterinaria. 2010;60:105–21.
Chorley BN, Li Y, Fang S, Park JA, Adler KB. (R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS. Am J Respir Cell Mol Biol. 2006;34:119–27.
Ko L, Rotoli G, Grignol G, Hu W, Merchenthaler I, Dudas B. A putative morphological substrate of the catecholamine-influenced neuropeptide Y (NPY) release in the human hypothalamus. Neuropeptides. 2011;45:197–203.
Lim HY, Muller N, Herold MJ, van den Brandt J, Reichardt HM. Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology. 2007;122:47–53.
Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol. 2008;4:525–33.
Flierl MA, Rittirsch D, Nadeau BA, Sarma JV, Day DE, Lentsch AB, Huber-Lang MS, Ward PA. Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response. PLoS ONE. 2009;4:e4414.
Lucin KM, Sanders VM, Popovich PG. Stress hormones collaborate to induce lymphocyte apoptosis after high level spinal cord injury. J Neurochem. 2009;110:1409–21.
Shimizu H, Arima H, Watanabe M, Goto M, Banno R, Sato I, Ozaki N, Nagasaki H, Oiso Y. Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats. Endocrinology. 2008;149:4544–53.
Wisialowski T, Parker R, Preston E, Sainsbury A, Kraegen E, Herzog H, Cooney G. Adrenalectomy reduces neuropeptide Y-induced insulin release and NPY receptor expression in the rat ventromedial hypothalamus. J Clin Invest. 2000;105:1253–9.
Damoiseaux JG, Dopp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology. 1994;83:140–7.
Mensah-Brown EP, Shahin A, Al Shamisi M, Lukic ML. Early influx of macrophages determines susceptibility to experimental allergic encephalomyelitis in Dark Agouti (DA) rats. J Neuroimmunol. 2011;232:68–74.
Cao C, Lawrence DA, Strickland DK, Zhang L. A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics. Blood. 2005;106:3234–41.
Greeson JM, Lewis JG, Achanzar K, Zimmerman E, Young KH, Suarez EC. Stress-induced changes in the expression of monocytic beta2-integrins: the impact of arousal of negative affect and adrenergic responses to the Anger Recall Interview. Brain Behav Immun. 2009;23:251–6.
Burton OT, Zaccone P, Phillips JM, De La Pena H, Fehervari Z, Azuma M, Gibbs S, Stockinger B, Cooke A. Roles for TGF-beta and programmed cell death 1 ligand 1 in regulatory T cell expansion and diabetes suppression by zymosan in nonobese diabetic mice. J Immunol. 2010;185:2754–62.
Du Q, Min S, Chen LY, Ma YD, Guo XL, Wang Z, Wang ZG. Major stress hormones suppress the response of macrophages through down-regulation of TLR2 and TLR4. J Surg Res;2010.
Sesti-Costa R, Baccan GC, Chedraoui-Silva S, Mantovani B. Effects of acute cold stress on phagocytosis of apoptotic cells: the role of corticosterone. NeuroImmunoModulation. 2010;17:79–87.
Stanojevic S, Kustrimovic N, Mitic K, Miletic T, Vujic V, Kovacevic-Jovanovic V, Dimitrijevic M. The effects of corticosterone and beta-endorphin on adherence, phagocytosis and hydrogen peroxide production of macrophages isolated from Dark Agouti rats exposed to acute stress. NeuroImmunoModulation. 2008;15:108–16.
Acknowledgments
We wish to thank our colleagues, Katarina Mitic PhD, Vesna Vujic PhD, Vesna Kovacevi-Jovanovic PhD, Dusko Kosec PhD, Katarina Radojevic PhD and Aleksandra Rauski for valuable help in the research and stimulating discussion of the results that helped us to shape this review. This work was supported by Grant (175050) from the Ministry of Education and Science, Belgrade, Serbia.
Author information
Authors and Affiliations
Corresponding author
Additional information
Mirjana Dimitrijevic, Stanislava Stanojevic, and Gordana Leposavic equally contributed to this work.
Rights and permissions
About this article
Cite this article
Dimitrijevic, M., Stanojevic, S., Kustrimovic, N. et al. End-point effector stress mediators in neuroimmune interactions: their role in immune system homeostasis and autoimmune pathology. Immunol Res 52, 64–80 (2012). https://doi.org/10.1007/s12026-012-8275-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-012-8275-9